Our community, Blue Circle Diabetes Foundation along with several others across the globe have been advocating for the inclusion of rapid acting analogue insulins & GLP-1s to the WHO Essential Medicine List to make them more accessible & affordable for whoever needs them
The FLOW trial demonstrated meaningful reductions in kidney disease progression with semaglutide. The SELECT trial showed a 20% reduction in major adverse cardiovascular events in patients with obesity and established cardiovascular disease. These are not trivial findings
However, individuals with Wilsons disease or copper metabolism disorders should exercise extreme caution
Although the role of Th17 in depression has not been fully clarified, and research on the correlation between IL-17 and depression is still limited, accumulating evidence have pointed to the involvement of Th17 and IL-17 in depression
This amazing health-risk-assessment technology delivers: A full-body scan in under a minute Millions of precise measurements within 2mm accuracy A 3D avatar to visually compare monthly results Styku goes beyond weight, tracking fat loss, muscle gain, posture, and even metabolic risk
.jpg)
